Aposense

Aposense is a molecular imaging and drug development company, with a pipeline of products, based on its apoptosis-based technology.

Aposense (formerly NST) is a clinical stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. Aposense is translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple disease categories, including oncology, cardiology and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.